Tags |
|
|
Links |
|
|
Main Subject - Lucrative Email Marketing
According to a research conducted, around 97% of the consumers and about
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
94% of the marketers are making use of emails and what is more, markete
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
rs are finding these users of emails a target for their marketing effort
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s to direct on. Studies reveal that these lovers of emails are the ones
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ho spend more time online and are impulsive buyers. There are the ones w
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ho are wiling for convenience and believe in advocating and forwarding e
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
mails that they find are worth something.
It is true that for the past
It is true that for the past
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
few years, the email click-through rates have been hovering around the 5
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
mark but then also this 5% is really steady and they are still valuable
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
. It is also seen that the people who purchase items that are advertised
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
in emails spend about 138% more time online as compared to people who d
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
on’t purchase items through emails. This year is going to witness more m
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
tured and sophisticated email strategies and as a marketer one needs to
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
be aware of the changing consumer behavior and respond to it accordingly
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
. Then only one would be able to maximize response rates and turn it int
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
o sales. What is more, they also need to put adequate analytics in place
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
so that the data that are generated could be turned into valuable inform
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ation.
If you really want to turn into an email marketer that actually
If you really want to turn into an email marketer that actually
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
proves productive, you would need two things. You would need a list of e
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
mail address and you would need ezine or newsletter with quality content
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/61840/mainsubjects-Lucrative-Email-Marketing.html">Lucrative Email Marketing</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/61840/mainsubjects-Lucrative-Email-Marketing.html]Lucrative Email Marketing[/url]
Related Articles:
Bookmark it:
|